Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2016
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Description The report provides comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/145965 . Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/145965 . For more information contact sales@orbisresearch.com Scope - The report provides a snapshot of the global therapeutic landscape of Congestive Heart Failure (Heart Failure) - The report reviews pipeline therapeutics for Congestive Heart Failure (Heart Failure) by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Congestive Heart Failure (Heart Failure) therapeutics and enlists all their major and minor projects - The report assesses Congestive Heart Failure (Heart Failure) therapeutics based on drug target,
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Congestive Heart Failure (Heart Failure) Browse Complete Report @ http://www.orbisresearch.com/reports/index/congestive-heart-failureheart-failure-pipeline-review-h2-2016 . List of Figures Number of Products under Development for Congestive Heart Failure (Heart Failure), H2 2016 22 Number of Products under Development for Congestive Heart Failure (Heart Failure) - Comparative Analysis, H2 2016 23 Number of Products under Development by Companies, H2 2016 24 Number of Products under Investigation by Universities/Institutes, H2 2016 30 Comparative Analysis by Late Stage Development, H2 2016 32 Comparative Analysis by Clinical Stage Development, H2 2016 33 Comparative Analysis by Early Stage Products, H2 2016 34 Assessment by Monotherapy Products, H2 2016 105 Number of Products by Top 10 Targets, H2 2016 107 Number of Products by Stage and Top 10 Targets, H2 2016 107 Number of Products by Top 10 Mechanism of Actions, H2 2016 113 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016 113 Number of Products by Top 10 Routes of Administration, H2 2016 119 Number of Products by Stage and Top 10 Routes of Administration, H2 2016 119 Number of Products by Top 10 Molecule Types, H2 2016 121 Number of Products by Stage and Top 10 Molecule Types, H2 2016 121 For any enquires before buying, connect with us @ enquiry@orbisresearch.com About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Phone No.: +1 (214) 884-6817; +9164101019 Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research Follow us on Twitter: https://twitter.com/orbisresearch Like us on Facebook: https://www.facebook.com/OrbisResearch
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019